검색어 : 통합검색[Praet Peter van.]
총 80건 중 80건 출력
, 8/8 페이지
-
71
- Outcomes after robot-assisted radical cystectomy with orthotopic neobladder in women
- Rautiola, Juhana; Martini, Alberto; Mertens, Laura S; Skokic, Viktor; Di Gianfrancesco, Luca; Bravi, Carlo Andrea; Heinzelbecker, Julia; Mendrek, Mikolaj; Buse, Stephan; Ploussard, Guillaume; John, Hubert; Canda, Abdullah Erdem; Balbay, Mevlana Derya; Edeling, Sebastian; Van Praet, Charles; Leyh-Bannurah, Sami-Ramzi; Mottrie, Alexander; D’Hondt, Frederiek; van der Poel, Hendrik; Berquin, Camille; Dacaestecker, Karel; Gaston, Richard; Wiklund, Peter; Hosseini, Abolfazl; ; (World journal of urology, v.42, 2024, pp.617)
-
72
- O-0030 Long Term Survival Data from EORTC Study 40983: Perioperative Chemotherapy for Resectable Liver Metastases from Colorectal Cancer
- Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; John Poston, Graeme; Schlag, Peter M.; Rougier, Philippe; Bechstein, Wolf; Neil Primrose, John; Walpole, Euan Thomas; Finch-Jones, Meg; Jaeck, Daniel; Mirza, Darius; Parks, Rowan W.; Collette, Laurence; Praet, Michel; Van Cutsem, Eric; Scheithauer, Werner; Mauer, Murielle E.; Gruenberger, Thomas; ; (Annals of oncology : official journal of the European Society for Medical Oncology, v.23, 2012, pp.iv18)
-
73
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
- Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; Poston, Graeme J; Schlag, Peter M; Rougier, Philippe; Bechstein, Wolf O; Primrose, John N; Walpole, Euan T; Finch-Jones, Meg; Jaeck, Daniel; Mirza, Darius; Parks, Rowan W; Collette, Laurence; Praet, Michel; Bethe, Ullrich; Van Cutsem, Eric; Scheithauer, Werner; Gruenberger, Thomas; Centre Hospitalier Universitaire Ambroise Paré , Assistance Publique Hô pitaux de Paris, Departments of Surgery and Oncology, Boulogne-Billancourt, France; Haukeland University Hospital, University of Bergen, Department of Oncology, Bergen, Norway; Department of Oncology, Radiology, and Clinical Immunology, Uppsala University, Uppsala, Sweden; University Hospital Aintree, Liverpool, UK; Robert-Roessle-Klinik, Humboldt-Universitä t Berlin, Surgery Department, Berlin, Germany; Centre Hospitalier Universitaire Ambroise Paré , Assistance Publique Hô pitaux de Paris, Departments of Surgery and Oncology, Boulogne-Billancourt, France; Klinikum der Johann-Wolfgang-Goethe-Universitä t, Department of General and Vascular Surgery, Frankfurt am Main, Germany; University Department of Surgery, Southampton General Hospital, Southampton, UK; Princess Alexandra Hospital— University of Queensland, Woolloongabba, Brisbane, Australia, Australasian Gastro-Intest; (The Lancet, v.371, 2008, pp.1007-1016)
-
74
- LBA03-01 <sup>89</sup> Zr-DFO-GIRENTUXIMAB FOR PET/CT IMAGING OF INDETERMINATE RENAL MASSES-RESULTS FROM PHASE 3 ZIRCON STUDY
- Shuch, Brian; Pantuck, Allan J.; Bernhard, Jean-Christophe; Morris, Michael A.; Master, Viraj; Scott, Andrew; van Praet, Charles; Bailly, Clement; Ö nal, Bü lent; Aksoy, Tamer; Merkx, Robin; Schuster, David M.; Lee, Sze Ting; Pandit-Taskar, Neeta; Fan, Alice C.; Tauchmanova, Libuse; Schmidt, Karl; Vadali, Kavita; Hayward, Colin; Mulders, Peter; ; (The Journal of urology : official journal of the American Urological Association, Inc, v.209, 2023, )
-
75
- Interleukin‐13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages
- Guglielmetti, Caroline; Le Blon, Debbie; Santermans, Eva; Salas‐ Perdomo, Angelica; Daans, Jasmijn; De Vocht, Nathalie; Shah, Disha; Hoornaert, Chloé ; Praet, Jelle; Peerlings, Jurgen; Kara, Firat; Bigot, Christian; Mai, Zhenhua; Goossens, Herman; Hens, Niel; Hendrix, Sven; Verhoye, Marleen; Planas, Anna M.; Berneman, Zwi; van der Linden, Annemie; Ponsaerts, Peter; Bio‐ Imaging Laboratory, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Experimental Hematology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Center for Statistics, I‐ Biostat, Hasselt University, Hasselt, Belgium; Department of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomè diques de Barcelona (IIBB), Consejo Superior de Investigaciones Cientí ficas (CSIC), Institut d'Investigacions Biomè diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Laboratory of Experimental Hematology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Bio‐ Imaging Laboratory, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgi; (GLIA, v.64, 2016, pp.2181-2200)
-
76
- Results from phase 3 study of <sup>89</sup>Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).
- Shuch, Brian M.; Pantuck, Allan J.; Bernhard, Jean-Christophe; Morris, Michael A.; Master, Viraj A.; Scott, Andrew Mark; Van Praet, Charles; Bailly, Clé ment; Aksoy, Tamer; Merkx, Robin; Schuster, David M.; Lee, Sze Ting; Pandit-Taskar, Neeta; Fan, Alice C.; Tauchmanova, Libuse; Allman, Phillip; Vadali, Kavita; Hayward, Colin; Mulders, Peter; Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA; CHU Bordeaux, Bordeaux, France; Advanced Molecular Imaging and Therapy, Glen Burnie, MD; Emory University, Atlanta, GA; Department of Molecular Imaging and Therapy, Austin Health and University of Melbourne; Olivia Newton-John Cancer Research Institute and La Trobe University, Heidelberg, Australia; Department of Urology, Universitair Ziekenhuis, Gent, Belgium; CHU de Nantes, Hotel Dieu - HME, Nantes, France; Istanbul Training and Research Hospital, Istanbul, Turkey; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands; Department of Radiology and Imaging Sciences, Division of Nuclear Medicine and Molecular Imaging, Emory University, Atlanta, GA; Department of Molecular Imaging and Therapy, Austin Health and University of Melbourne; Olivia Newton-John Cancer Research; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.41, 2023, pp.LBA602-LBA602)
-
77
- <sup>89</sup>Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma: Results from phase 3 ZIRCON study.
- Shuch, Brian M.; Pantuck, Allan J.; Bernhard, Jean-Christophe; Morris, Michael; Master, Viraj A.; Scott, Andrew Mark; Van Praet, Charles; Bailly, Clé ment; Onal, Bulent; Aksoy, Tamer; Merkx, Robin; Schuster, David M.; Lee, Sze Ting; Pandit-Taskar, Neeta; Fan, Alice C.; Tauchmanova, Libuse; Schmidt, Karl; Vadali, Kavita; Hayward, Colin; Mulders, Peter; Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA; CHU Bordeaux, Bordeaux, France; Advanced Molecular Imaging and Therapy, Glen Burnie, MD; Emory University, Atlanta, GA; Department of Molecular Imaging and Therapy, Austin Health and University of Melbourne; Olivia Newton-John Cancer Research Institute and La Trobe University, Heidelberg, Australia; Department of Urology, Universitair Ziekenhuis, Gent, Belgium; CHU de Nantes, Hotel Dieu - HME, Nantes, France; Istanbul University- Cerrahpasa, Cerrahpasa Medical Faculty, Urology Department, Istanbul, Turkey; Istanbul Training and Research Hospital, Istanbul, Turkey; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands; Department of Radiology and Imaging Sciences, Division of Nuclear Medicine and Molecular Imaging, Emory University, Atlanta, GA; Department of Molecula; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.41, 2023, pp.4554-4554)
-
78
- [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial
- Shuch, Brian; Pantuck, Allan J; Bernhard, Jean-Christophe; Morris, Michael A; Master, Viraj; Scott, Andrew M; van Praet, Charles; Bailly, Clement; Ö nal, Bü lent; Aksoy, Tamer; Merkx, Robin; Schuster, David M; Lee, Sze Ting; Pandit-Taskar, Neeta; Fan, Alice C; Allman, Phillip; Schmidt, Karl; Tauchmanova, Libuse; Wheatcroft, Michael; Behrenbruch, Christian; Hayward, Colin R W; Mulders, Peter; ; (The Lancet. Oncology, v.25, 2024, pp.1277-1287)
-
79
- Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis
- de Azambuja, Evandro; Brandã o, Mariana; Wildiers, Hans; Laenen, Annouschka; Aspeslagh, Sandrine; Fontaine, Christel; Collignon, Joelle; Lybaert, Willem; Verheezen, Jolanda; Rutten, Annemie; Vuylsteke, Peter; Goeminne, Jean-Charles; Demey, Wim; Van Beckhoven, Dominique; Deblonde, Jessika; Rottey, Sylvie; Geukens, Tatjana; Punie, Kevin; Bafort, Kristof; Belkhir, Lei¨la; Bossuyt, Nathalie; Colombie, Vincent; Daubresse, Christine; Dauby, Nicolas; Munter, Paul De; Delmarcelle, Didier; Delvallee, Mé lanie; Demeester, Ré my; Delefortrie, Quentin; Dugernier, Thierry; Holemans, Xavier; Louviaux, Ingrid; Machurot, Pierre Yves; Minette, Philippe; Mokrane, Saphia; Nachtergal, Catherine; Noirhomme, Sé verine; Pié rard, Denis; Rossi, Camelia; Schirvel, Carole; Sermijn, Erica; Staelens, Frank; Triest, Filip; Beckhoven, Dominique Van; Goethem, Nina Van; Praet, Jens Van; Vanhoenacker, Anke; Verstraete, Roeland; Willems, El; Department of Medical Oncology, Institut Jules Bordet and L’Université Libre de Bruxelles (U.L.B), Brussels, Belgium; EPI Unit - Instituto de Saú de Pú blica, Universidade do Porto, Porto, Portugal; Department of General Medical Oncology and Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, KU Leuven, Leuven, Belgium; Department of Medical Oncology, UZ Brussels, Jette, Belgium; Department of Medical Oncology, UZ Brussels, Jette, Belgium; Department of Medical Oncology, CHU Liè ge, Liè ge, Belgium; Department of Medical Oncology, AZ Nikolaas, Sint-Niklaas, Belgium; Department of Medical Oncology, St. Trudo Hospital, Sint-Truiden, Belgium; Department of Medical Oncology, GZA Ziekenhuizen, Campus Sint-Augustinus, Wilrijk, Belgium; Department of Medical Oncology, UCLouvain, CHU-UCL Namur, Namur, Belgium; Department of Med; (Esmo open, v.5, 2020, pp.e000947-e000947)
-
80
- How can we reduce morbidity after robot‐assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working Group
-
Pellegrino, Francesco;
Martini, Alberto;
Falagario, Ugo Giovanni;
Rautiola, Juhana;
Russo, Antonio;
Mertens, Laura S;
Di Gianfrancesco, Luca;
Bravi, Carlo Andrea;
Vollemaere, Jonathan;
Abdeen, Muhammad;
Moschini, Marco;
Mendrek, Mikolaj;
Kjøbli, Eirik;
Buse, Stephan;
Wijburg, Carl;
Touzani, Alae;
Ploussard, Guillaume;
Antonelli, Alessandro;
Schwenk, Laura;
Ebbing, Jan;
Vasdev, Nikhil;
Froelicher, Gabriel;
John, Hubert;
Canda, Abdullah Erdem;
Balbay, Mevlana Derya;
Stoll, Marcel;
Edeling, Sebastian;
Berquin, Camille;
Van Praet, Charles;
Leyh‐
Bannurah, Sami‐
Ramzi;
Siemer, Stefan;
Stoeckle, Michael;
Mottrie, Alexander;
D'Hondt, Frederiek;
Crestani, Alessandro;
Porreca, Angelo;
Briganti, Alberto;
Montorsi, Francesco;
van der Poel, Hendrik;
Dacaestecker, Karel;
Gaston, Richard;
Hosseini, Abolfazl;
Wiklund, N. Peter;
Division of Oncology/Unit of Urology, URI, IRCCS San Raffaele Scientific Institute, Milan, Italy;
Department of Molecular Medicine and Surgery, Karolinska institute, Stockholm, Sweden;
Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy;
Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France;
Department of Urology, IRCCS Ospedale San Raffaele, Milan, Italy;
Oncological Urology, IRCCS Veneto Institute of Oncology, Padua, Italy;
Department of Urology, OLV Hospital, Aalst, Belgium;
Orsi Academy, Ghent, Belgium;
Department of Urology, Urologic Oncology and Robot‐
assisted Surgery, St. Antonius Hospital, Gronau, Germany
QUICK MENU
